Antiretrovirals are being procured by the South African government for only 5% of the price it was paying for them in 2001. This amazing decrease in ARV prices is a result of the voluntary licences granted by multi-nationals to generics manufacturers.
South African company Aspen Pharmacare currently sells a triple therapy generic ARV treatment consisting of 150mg Lamivudine, 40mg Stavudine and 200mg nevirapine to government for R97,27 per person a month.
According to the first edition of the report Accessing ARVs: Untangling the Web of Price Reductions for Developing Countries, by MÃ